Thomas Raffin

Administrative Appointments

• Course Founder and Director - Ethical Values in Health Care: Lessons from the Nazi Period, Stanford University Undergraduate Curriculum (1994 - 1996)
• Course Founder and Director - Intensive Life Support Systems: Present Practice and Moral Issues, Stanford University Undergraduate Curriculum (1984 - 1988)
• Co-Founder and Co-Director, Stanford Program in Genomics, Ethics and Society (1995 - present)
• Co-Founder, Hutchison Program in Translational Medicine at Stanford University($5,000,000) (1998 - 2003)
• Consultant, Nektar, Inc. (1999 - present)
View All 10administrative appointments of Thomas Raffin

Honors and Awards

• Henry J. Kaiser Foundation Award for Excellence in Preclinical Teaching, Stanford University Medical School (1997)
• Henry J. Kaiser Award for Excellence in Clinical Teaching, Stanford University Medical School (1988)
• Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching, Stanford University Medical School (1984)
• Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine, Stanford University Medical School (1981)
• Henry J. Kaiser Foundation Award for Excellence in Clinical Teaching, Stanford University Medical School (1980)

Professional Education

Graduate & Fellowship Program Affiliations

• Health Research and Policy
• Health Services Research
• Medicine

Community & International Work

• Stanford University-Asia Medical Fund, Stanford University 

Web Site Links

• Stanford Center for Biomedical Ethics

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Research Interests

Acute lung tissue injury is often mediated by neutrophils. Our laboratory studied the basic biology of neutrophils and mechanisms of neutrophil-mediated pulmonary injury. Investigative approaches included the molecular biology of neutrophil activation, neutrophil ion channel regulation, mechanisms of signal transduction with an emphasis on protein phosphorylation, control of neutrophil activation and the use of animal models to investigate the use of agents and intermediaries which might attenuate neutrophil-mediated acute lung injury. Besides these areas of basic investigation, clinical studies in biomedical ethics were also pursued. For example: End-of-life decision making, differences in informed consent and decision making between patients and physicians in Japan and America, the efficacy of ethics committees in the United States, the new role of biomedical ethics in managed care; social, ethical and legal issues in genomics and genetic testing, and neuroethics.

Publications

• Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Illes J, Kann D, Karetsky K, Letourneau P, Raffin TA, Schraedley-Desmond P, Koenig BA, Atlas SW. Arch Intern Med. 2004 Dec 13-27; 164 (22): 2415-9
• Ethical consideration of incidental findings on adult brain MRI in research. Illes J, Rosen AC, Huang L, Goldstein RA, Raffin TA, Swan G, Atlas SW. Neurology. 2004; 62 (6): 888-90
• Chylothorax after heart/lung transplantation. Ziedalski TM, Raffin TA, Sze DY, Mitchell JD, Robbins RC, Theodore J, Faul JL. J Heart Lung Transplant. 2004; 23 (5): 627-31
• Discovery and disclosure of incidental findings in neuroimaging research. Illes J, Kirschen MP, Karetsky K, Kelly M, Saha A, Desmond JE, Raffin TA, Glover GH, Atlas SW. J Magn Reson Imaging. 2004; 20 (5): 743-7
• Thoracic lymphatic disorders. Davis KK, Berry GJ, Raffin TA, Faul JL. Lymphat Res Biol. 2004; 2 (3): 131-7